Assay Development DNA Drug Development 
Drug Discovery World
JANUARY 19, 2023
This paid-for advertorial by Catalent appeared in DDW Volume 24 – Issue 1, Winter 2022/2023 One significant challenge in the manufacturing of cell and gene therapies is the production of high-quality plasmid DNA (pDNA). Figure 1: The integrated development pathway for cell and gene therapies. billion by 2030 (BioSpace, 11 August 2022).
Drug Discovery World
APRIL 25, 2024
Reece Armstrong offers an overview of cell line development and outlines the benefits the technology is bringing to biopharmaceutical developers. Cell line development is an essential underpinning of the drug development process, enabling teams to test, optimise and manufacture therapeutics at a commercial scale.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
MAY 11, 2023
In addition, their cumbersome developmental process limits their use for fast-tracked new modalities, such as DNA-based vaccines. Novel gene-based drugs can be severely impacted when HCPs are not distinguished and quantified individually. LC-MS can prove valuable not only in quality control, but also in early development phases.
Elrig
APRIL 29, 2024
Srinivasan has led the development of multiple computational pipelines to process data from different next generation sequencing techniques with applications in oncology, genome editing systems including CRISPR-Cas mediated DNA editing, and ADAR-mediated RNA editing.
Agency IQ
FEBRUARY 2, 2024
The EMA started providing guidance on the clinical development of anticancer therapeutics in 1996. The document has been updated over time to implement advances in understanding cancer and drug development. In 2005, the guidance was updated to include non-cytotoxic drugs were gaining in importance.
Expert insights. Personalized for you.
130 
Let's personalize your content